What teens (11–17) and their parents think about hormone replacement for female hypogonadism
Official title: Current Knowledge and Perceptions of Hormone Replacement Therapy Among Patients Aged 11 to 18 Years, and Their Parents, Treated for Hypogonadism at the Strasbourg University Hospital
Run by University Hospital, Strasbourg, France · NCT07315932 · Data updated 2026-11-12
We will ask girls aged 11–17 with hypogonadism and their parents about their knowledge and feelings on hormone replacement therapy to see what education helps them stick with treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 11 Years to 18 Years |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | March 23, 2025 |
| Main results expected | February 2026 |
| Study ends | February 2026 |
| Registry record updated | January 5, 2026 |
| Trial ID | NCT07315932 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are girls aged 11–17 treated at CHU Strasbourg for central or peripheral hypogonadism who have recently started hormone replacement therapy and whose parents can participate.
✕Probably not a fit
Patients who cannot understand the study information (because of language barriers, illiteracy, or cognitive difficulties) or those treated outside the recruiting center are unlikely to benefit from this single-center effort.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project recruits female patients aged 11–17 treated at the University Hospital of Strasbourg for central or peripheral hypogonadism who have started hormone replacement therapy. Patients and their parents complete questionnaires and/or interviews about knowledge, beliefs, barriers, and practical challenges related to HRT. Responses are analyzed to identify common gaps and educational needs. The results will inform the design of therapeutic education workshops to improve understanding and adherence; no experimental treatments are administered.
Why it matters
Potential benefit: If successful, the project could improve patient and parent understanding of HRT and increase adherence, potentially improving clinical outcomes.
How similar studies have gone: Educational interventions in other pediatric endocrine and chronic conditions have improved adherence, but specific data on adolescent perceptions of HRT are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patients aged 11 to 18 years * Treated at the University Hospital of Strasbourg for central or peripheral hypogonadism with the initiation of hormone replacement therapy Exclusion Criteria: \- Inability to provide the subject with clear information (difficulties understanding the subject, language barrier, illiteracy, etc.)
Where it's running
-
Service de Gynécologie et obstétrique - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Mathilda KRETZ, MD
- Email: mathilda.kretz@chru-strasbourg.fr
- Phone: 33 3 88 11 67 68
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.